SciELO - Scientific Electronic Library Online

 
vol.41 issue6Bariatric surgery: impact on sexuality of the obese personUltrasound evaluation on carpal tunnel syndrome before and after bariatric surgery author indexsubject indexarticles search
Home Pagealphabetic serial listing  

Services on Demand

Journal

Article

Indicators

Related links

Share


Revista do Colégio Brasileiro de Cirurgiões

Print version ISSN 0100-6991On-line version ISSN 1809-4546

Rev. Col. Bras. Cir. vol.41 no.6 Rio de Janeiro Nov./Dec. 2014

http://dx.doi.org/10.1590/0100-69912014006007 

Original Articles

Hypothalamic-pituitary-gonadal function in men with liver cirrhosis before and after liver transplantation

Bruno T. Zacharias 1  

Julio C. U. Coelho 2  

Mônica B. Parolin 3  

Jorge E. F. Matias 1  

Alexandre C. T. de Freitas 1  

José Luiz de Godoy 3  

1Department of Surgery of the Digestive System, Clinics Hospital, Federal University of Paraná, Curitiba, Paraná - PR, Brazil

2Service of Surgery of the Digestive System and Liver Transplantation, Federal University of Paraná

3Liver Transplantation Service, Federal University of Paraná


ABSTRACT

Objective:

To evaluate the influence of end-stage liver disease and orthotopic liver transplantation in the pituitary function and hormone metabolism before and after liver transplantation.

Methods:

In a prospective study, serum levels of follicle stimulating hormone (FSH), luteinizing hormone (LH), estradiol (E2) and prolactin (PRL) of 30 male patients with cirrhosis were determined two to four hours before and six months after liver transplantation. The results were compared according to the Model for End-stage Liver Disease (MELD).

Results:

male patients with liver cirrhosis have hypogonadism. FSH was normal, but inappropriately low due to androgen failure; E2 and PRL, on their turn, were high. After liver transplantation, FSH and LH levels increased (p < 0.05), whereas E2 and PRL normalized (p < 0.05). The MELD score did not influence changes in FSH, PRL and LH, however, the more severe the cirrhosis was, the more significant was the normalization of E2 (p = 0.01).

Conclusion:

Patients with cirrhosis and male hypogonadism have inappropriately normal levels of FSH and LH, associated with an increase in E2 and LRP. After liver transplantation, FSH and LH increased, while E2 and PRL returned to normal. Changes in E2 levels were most pronounced in patients with MELD > 18. The severity of cirrhosis had no influence on FSH, PRL and LH.

Key words: Liver Transplantation; Liver Cirrhosis; Pituitary Gland; Hypogonadism

RESUMO

Objetivo:

avaliar a influência da doença hepática terminal e do transplante hepático ortotópico na função hipofisária e no metabolismo hormonal através da aferição dos níveis séricos dos hormônios folículo estimulante (FSH), hormônio luteinizante (HL), estradiol (E2) e prolactina (PRL) antes e após o transplante hepático.

Métodos:

em um estudo prospectivo, níveis séricos dos hormônios folículo estimulante (FSH), hormônio luteinizante (HL), estradiol (E2) e prolactina (PRL) de 30 paciente masculinos com cirrose foram determinados duas a quatro horas antes e seis meses após o transplante hepático. Os resultados foram comparados de acordo com o Model for End-stage Liver Disease (MELD).

Resultados:

acientes masculinos com cirrose hepática apresentam hipogonadismo. O FSH encontravam-se normais, porém inapropriadamente baixos devido à falência androgênica; já o E2 e o PRL estavam elevados. Após o transplante hepático, os níveis de FHS e HL aumentaram (p < 0,05), enquanto o E2 e o PRL normalizaram (p < 0,05). O MELD não influenciou as alterações no FSH, HL ou PRL, todavia, quanto mais grave a cirrose, mais significante foi a normalização do E2 (p=0,01).

Conclusão:

pacientes masculinos com cirrose e hipogonadismo apresentam níveis inapropriadamente normais de FSH e HL, associados com elevação do E2 e PRL. Após o transplante hepático, FSH e HL aumentaram, enquanto E2 e PRL retornaram aos valores normais. As alterações nos níveis de E2 foram mais pronunciadas em pacientes com MELD > 18. A gravidade da cirrose não teve influência no FSH, HL e PRL.

Palavras-Chave: Transplante de Fígado; Cirrose Hepática; Hipófise; Hipogonadismo

INTRODUCTION

Patients with end-stage liver disease have several endocrine dysfunctions, which include alterations in the functioning of the hypothalamic-pituitary-gonadal axis and the serum levels of sex hormones 1 - 4. Testicular atrophy, decrease in libido, impotence, oligospermia, infertility, loss of body hair, reduction of prostate size, gynecomastia, vascular spiders, gynecoid distribution of fat and palm erythema are often found in cirrhotic men 5 - 10. These findings are more pronounced in patients with alcoholic cirrhosis due to the direct harmful effect of ethanol to the testicles. The pathophysiology of hypogonadism in patients with advanced liver disease is complex and controversial.

Few studies have evaluated the dysfunction of the hypothalamic-pituitary-gonadal axis in men with cirrhosis before and after orthotopic liver transplantation (OLT). The correlation between changes in serum levels of sex hormones and the MELD score (Model for End-stage Liver Disease) has not yet been studied.

The aim of this study was to evaluate the influence of terminal liver disease and OLT in the pituitary function and hormone metabolism by measurement of serum levels of follicle stimulating hormone (FSH), luteinizing hormone (LH), estradiol (E2) and prolactin (PRL) before and after liver transplantation.

METHODS

Between August 2008 and April 2011, 93 liver transplants were performed at the Clinics Hospital of the Federal University of Paraná. The study included all male patients who did not present any of the following exclusion criteria: patients submitted to living-donor transplantation, re-transplantation, multivisceral transplantation, domino transplant and split liver transplant. Five patients who died were also excluded. In total, 30 men were selected and prospectively followed.

We used the Child-Pugh and MELD scores to determine the severity of liver disease. Among those included in the study, three patients (12%) were Child-Pugh class A, 6 (24%) class B, and 16 (64%) class C. The MELD ranged from 10 to 30 points, averaging 17.7 + 4.2 (95% CI 16.1-19.2). We did not consider the additional scores for cirrhotic patients with associated hepatocellular carcinoma. To evaluate the relationship between the severity of liver disease and the variation in the levels of sex hormones, we divided the study subjects into two groups, based on MELD classification, 17 patients with MELD <18, and 13 with MELD e" 18.

The mean age was 51.4 ± 7.6 years. The main causes of cirrhosis were infection with hepatitis C and alcohol abuse (Table 1). All patients with alcoholic cirrhosis were abstinent for more than six months prior to OLT.

Table 1 -  Clinical and Demographic Characteristics of patients. 

Features Patients
Number 30
Age (in years)
Mean ± Sd 51.4 ± 7.6
Variation 25 – 64
IC 95% 48.6 – 54.3
Gender (male/female) 30/0
Etiology of cirrhosis N (%)
HCV infection 10 (33.33)
Alcohol abuse 8 (26.67)
NASH 3 (10.0)
HBV infection 2 (6.67)
Hemochromatosis 2 (6.67)
Other 5 (16.67)
Associated Hepatocarcinoma 4 (13.33)
CI = confidence interval; SD = standard deviation; HCV = hepatitis C virus; HBV = hepatitis B virus; NASH = Nonalcoholic Steatohepatitis.

After liver transplantation, all patients underwent the same standard protocol of immunosuppressive therapy, consisting of cyclosporine or tacrolimus, mycophenolate mofetil and corticoids.

We collected peripheral blood samples two to four hours before induction of anesthesia and six months after liver transplantation, with determination of levels of FSH, LH, E2 and PRL through commercial immunoassay kits. We also measured total bilirubin, prothrombin and creatinine by routine biochemical tests for determining the MELD score on the day of transplantation.

The study protocol was in accordance with guidelines of the Helsinki Declaration of 1975, and was approved by the Ethics Committee of the Clinics Hospital of the Federal University of Paraná, Brazil (CAAE: 0159.0.208.000-08, CEP Registration: 1712.129 / 2008- 07). All patients signed an informed consent form to participate in the study.

Statistical Analysis

The measures of central tendency and dispersion are expressed as means and standard deviation (mean ± SD) for symmetrically distributed, continuous variables, and as median, minimum and maximum values for the ones with asymmetric distribution.

The estimated difference of continuous variables with normal distribution were analyzed by parametric tests, Student's t test for dependent samples, and ANOVA for repeated measures, while for asymmetric distribution variables we employed the non-parametric Wilcoxon and Friedman ANOVA tests. We applied the McNemar test in the study of the behavior of biochemical and hormonal variables according to the reference values, evaluating the categories' variations: normal, below and above the reference value, before and after liver transplantation. The results were considered statistically significant when p d" 0.05.

RESULTS

The FSH and LH levels were within normal limits and increased, respectively, from 8.1 mIU/ml to 13.4 mIU/ml (p = 0.002) and from 4.6 mIU/mL to 9.9 mIU/ml (p <0.001) after OLT. Estradiol was initially high, and returned to normal after liver transplantation (p = 0.001). Prolactin levels were also elevated preoperatively. After OLT its levels decreased to normal (p <0.001) (Table 2).

Table 2 -  Serum levels of FSH, LH, PRL and EE. 

Hormone Reference Pre-OLT Post-OLT p
FSH 1.5 – 12.4 mUI/mL 8.1 (0.7 – 73.0) 13.4 (2.2 – 92.5) 0.002
HL 1.7 – 8.6 mUI/mL 4.6 (1.3 – 34.0) 9.9 (2.9 – 82.2) < 0.001
E2 < 43 pg/mL 54.7 (26.0 – 466.0) 33.5 (15.5 – 314.0) 0.001
PRL 2.0 – 15.2 ng/mL 16.5 (4.8 – 68.1) 8.4 (3.2 – 29.0) < 0.001

OLT = Orthotopic Liver Transplantation; FSH = Follicle Stimulating Hormone; HL = Luteinizing Hormone; E2 = Estradiol; PRL = Prolactin.

The multivariate analysis based on generalized linear models showed no influence of age on the date of transplantation or the etiology of cirrhosis in the hormonal changes observed.

In both MELD groups we observed a rise in serum FSH values before and after OLT (p = 0.004), but without significant difference (p = 0.89) (Figure 1). There was an increase in HL in the MELD group < 18 (p = 0.01), while there was no change in the MELD group e" 18 (p = 0.26). Nor was there a significant difference between groups (p = 0.89) (Figure 2). There was a drop in estradiol values after OLT both in the group with MELD <18 (p = 0.05) and in the one with MELD e" 18 (p = 0.005), being more pronounced in the group with Meld e" 18 (p = 0.006) (Figure 3). There was a reduction in serum prolactin levels in the MELD group <18 (p = 0.03) and MELD e" 18 (p = 0.005), with no statistically significant difference (p = 0.07) (Figure 4).

Figure 1 -  Orthotopic liver transplantation (OLT); follicle stimulating hormone (FSH). Increased serum FSH levels in both groups MELD < 18 and MELD e" 18 (p = 0.04), with no difference between them (p = 0.89). 

Figure 2 -  Orthotopic liver transplantation (OLT); luteinizing hormone (LH). Increases in serum LH levels in the MELD group < 18 (p = 0.01), not observed in the MELD group e" 18 (p = 0.26), with no difference between them (p = 0.89). 

Figure 3 -  Orthotopic Liver Transplantation (OLT); estradiol (E2). Reduction in E2 levels in groups MELD < 18 (p = 0.05) and MELD score e" 18 (p = 0.005), more pronounced in the MELD group e" 18 (p = 0.01). 

Figure 4 -  Liver Transplantation Orthotopic (OLT); prolactin (PRL). Reduction in levels of PRL in the MELD groups < 18 (p = 0.03) and e" 18 (p = 0.005), with no difference between them (p = 0.07). 

DISCUSSION

Male patients with cirrhosis have a number of changes in the regulation of their sex hormones, resulting in hypogonadism and feminization. End-stage liver disease causes dysfunction in the hypothalamic-pituitary-gonadal axis and hormonal peripheral metabolism 1 , 2 , 11 , 12, resulting in a significant deterioration in quality of life 3 - 10.

Our prospective study showed that cirrhotic men have significant alterations in the pituitary regulatory functions, and that these disorders are completely reversed after liver transplantation.

The FSH and HL were at levels within their reference values, and increased after OLT 13. These data confirm the results of previous studies. However, it is important to note that serum levels of these hormones were inappropriately low, given the androgen failure evidenced in these patients 7 , 14 , 15. In fact, one would expect them to suffer a compensatory increase due to low serum testosterone levels. Our results showed that six months after transplantation the values of FSH and HL showed a significant increase, suggesting that the liver disease had a direct influence on this abnormality, which is consistent with the available literature on the subject 3 , 12 ,13 16.

The exact cause of this central dysfunction has not been clearly elucidated. It is speculated that liver cirrhosis alone can cause a malfunction of the hypothalamic-pituitary-gonadal axis1 , 3 , 10. Furthermore, high circulating levels of estradiol and prolactin also contribute to hypogonadism2 , 3, either by regulatory suppression or by direct inhibition of the testicular function10. The results also showed that both the PRL and E2 were at levels above normal in patients with end-stage liver disease, with normalization after OLT, in line with previous studies 1 , 17 , 18. The increase in serum levels of E2 is primarily due to increased peripheral conversion of androgens into estrogens and reduction in liver clearing function 5 , 7. Portal hypertension can lead to a diversion of blood flow from the liver to peripheral tissues, resulting in a further increase in the conversion of steroids into estrogens8. Although some studies 2 , 19 , 20 have established a correlation between increased PRL in cirrhosis and hyperestrogenemia, the mechanism that leads to hyperprolactinemia is not yet clear.

Another important finding of our study is the correction between these hormonal changes and the MELD score at the time of transplantation. It was found that the severity of liver disease has no influence on changes in FSH, LH and PRL (p = 0.89, p = 0.89 and p = 0.07, respectively) after OLT. This may be due to the limited number of patients included in this analysis.

However, E2 values decreased after liver transplantation in direct proportion with the worst liver function (p = 0.01). Furthermore, the higher the value of MELD at the time of OLT, the more significant the normalization of estradiol (p = 0.006).

Finally, after the evaluation of the impact of liver transplantation in the hypothalamic-pituitary-gonadal dysfunction in male cirrhotic patients, we observed that all hormone levels are normal six months after transplantation. This conclusion is consistent with the literature 3 , 7 , 10 , 13 , 16 - 18. Seehofer et al, after a five-year follow-up of their patients, found that this improvement is persistent 12.

The present study demonstrated that male patients with end-stage liver disease have inappropriately low levels of FSH and LH due to androgenic failure, and elevated serum E2 and PRL. After liver transplantation, FSH and LH values increased, while E2 and PRL returned to normal. Changes in estradiol are more pronounced in patients with higher MELD (MELD e" 18). Changes of FSH, PRL and LH did not vary according to the severity of liver disease.

REFERENCES

1. Zietza B, Locka G, Placha B, Drobnikb W, Grossmanna J, Scholmericha J, Strauba R. Dysfunction of the hypothalamic-pituitary-glandular axes and relation to Child-Pugh classification in male patients with alcoholic and virus-related cirrhosis. Eur J Gastroenterol Hepatol 2003; 15: 495-501. [ Links ]

2. Gonzales PH, Rhoden CR, Luz C, Correa G, Marbosa-Coutinho LM, Oliveira MC. Male gonadal function, prolactin secretion and lactotroph population in an experimental model of cirrhosis. Braz J Med Biol Res 2007; 40: 1383-8. [ Links ]

3. Heneghan M, Selzner M, Yoshida E, Mullhaupt B. Pregnancy and sexual function in liver transplantation. J Hepatol 2008; 49: 507-19. [ Links ]

4. Sorrell J, Brown J. Sexual Functioning in Patients With End-Stage Liver Disease Before and After Transplantation. Liver Transpl 2006;1 2: 1473-7. [ Links ]

5. Southren L, Gordon G, Olivo J, Rafii F, Rosenthal W. Androgen Metabolism in Cirrhosis of the Liver. Metabolism 1973; 22: 695-702. [ Links ]

6. Guichelaar M, Malinchoc M, Sibonga J, Clarke B, Hay J. Immunosuppressive and Postoperative Effects of Orthotopic Liver Transplantation on Bone Metabolism. Liver Transpl 2004; 10: 638-47. [ Links ]

7. Guechot J, Chazouilleres O, Loria A, Hannoun L, Balladur P, Parc R, Giboudeau J, et al. Effect of liver transplantation on sex-hormone disorders in male patients with alcohol-induced or post-viral hepatitis advanced liver disease. J Hepatol 1994; 20: 426-30. [ Links ]

8. Nolte W, Schindler C, Figulla H, Wuttke W, Huefner M, Hartmann H, Ramadori G. Increase of serum estradiol in cirrhotic men treated by transjugular intrahepatic portosystemic stent shunt. J Hepatol 2001; 34: 818-24. [ Links ]

9. Burra P, Germani G, Masier A, Martin E, Gambato M, Salonia A, Bo P, et al. Sexual dysfunction in chronic liver disease: Is liver transplantation an effective cure? Transplantation 2010; 89: 1425-9. [ Links ]

10. Karagiannis A, Harsoulis F. Gonadal dysfunction in systemic diseases. Eur J Endocrinol 2005; 152: 501-13. [ Links ]

11. Mowat N, Edwards C, Fisher R, McNeilly A, Green R, Dawson A. Hypothalamic-pituitary-gonadal function in men with cirrhosis of the liver. Gut 1976; 17: 345-50. [ Links ]

12. Seehofer D, Steinmueller T, Graef K, Rayes N, Wiegand W, Tullius S, Settmacher U, et al. Pituitary Function Test and Endocrine Status in Patient with Cirrhosis of the Liver before and after Hepatic Transplantation. Ann Transplant 2002; 7: 32-7. [ Links ]

13. Floreani A, Mega A, Tizian L, Burra P, Boccagni P, Baldo V, Fagiuoli S, et al. Bone Metabolism and Gonad Function in Male Patients Undergoing Liver Transplantation: A Two-Year Longitudinal Study. Osteoporos Int 2001; 12: 749-54. [ Links ]

14. Jabiry-Zienjewicz Z, Kaminski P, Bobrowska K, Pietrzak B, Wielgos M, Zieniewicz K, Krawczyk M. Menstrual Cycle and Sex Hormone Profile in Perimenopausal Women After Liver Transplantation. Transplant Proc 2006; 38: 2909-12. [ Links ]

15. Jabiry-Zienjewicz Z, Kaminski P, Bobrowska K, Pietrzak B, Wielgos M, Zieniewicz K, Krawczyk M. Menstrual Function in Female Liver Transplant Recipients of Reproductive Age. Transplant Proc 2009; 41: 1735-9. [ Links ]

16. Guichelaar M, Malinchoc M, Clarke B, Hay J. The Effect of Hypogonadism Before and After Orthothopic Liver Transplantation (OLT) on Bone Merabolism. J Hepatol 2003; 38: 60-6. [ Links ]

17. Monegal A, Navasa M, Guanabens N, Peris P, Pons F, Martinez OM, Ordi J, et al. Bone Disease After liver transplantation: A long-term prospective study of bone mass changes, hormonal status and sistomorphometric characteristics. Osteoporos Int 2001; 12: 484-92. [ Links ]

18. Aller R, de Luis D, Moreira V, Boixeda D, Moya J, Fernandez-Rodriguez C, San Román A, et al. The effect of liver transplantation on circulating levels of estradiol and progesterone in male patients: parallelism with hepatopulmonary syndrome and systemic hyperdynamic circulation improvement. J Endocrinol Invest 2001; 24: 503-9. [ Links ]

19. Morgan M, Jakobovits A, Gore M, Willis M, Sherlock S. Serum prolactin in liver disease and its relationship to gynaecomastia. Gut 1978; 19: 170-4. [ Links ]

20. Farthing M, Green J, Edwards C, Dawson A. Progesterone, prolactin, and gynaecomastia in men with liver disease. Gut 1982; 23: 276-9. [ Links ]

Source of funding: none.

Received: January 16, 2014; Accepted: March 20, 2014

Mailing address: Bruno T. Zacharias E-mail: brunozacharias@hotmail.com

Conflict of interest: none.

Creative Commons License This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License which permits unrestricted non-commercial use, distribution, and reproduction in any medium provided the original work is properly cited.